Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 108701-108750 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT03587662
Ixazomib, Gemcitabine, and Doxorubicin in Treating Patients With Locally Advanced or Metastatic Kidney Cancer
PHASE2
Active, not recruiting
30 participants
Started: Aug 17, 2018 · Completed: Jan 31, 2027
5 conditions
2 sponsors
1 location
NCT03490565
PREoperativ Study of Exercise Training
NA
Active, not recruiting
310 participants
Started: Aug 16, 2018 · Completed: Dec 31, 2028
1 condition
4 sponsors
1 location
NCT03363217
Trametinib for Pediatric Neuro-oncology Patients With Refractory Tumor and Activation of the MAPK/ERK Pathway.
PHASE2
Active, not recruiting
114 participants
Started: Aug 16, 2018 · Completed: Mar 1, 2027
3 conditions
3 sponsors
7 locations
NCT03456076
A Study Comparing Adjuvant Alectinib Versus Adjuvant Platinum-Based Chemotherapy in Patients With ALK Positive Non-Small Cell Lung Cancer
PHASE3
Active, not recruiting
257 participants
Started: Aug 16, 2018 · Completed: Nov 19, 2026
1 condition
1 sponsor
114 locations
NCT03447808
Daratumumab and Ibrutinib in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia
PHASE1
Active, not recruiting
15 participants
Started: Aug 16, 2018 · Completed: Apr 15, 2026
1 condition
1 sponsor
1 location
NCT03371667
To Compare the Efficacy of the Addition of Methotrexate (MTX) to Current Standard Acute Graft-versus-host Disease (GVHD) First-line Treatment With Corticosteroids
PHASE3
Active, not recruiting
102 participants
Started: Aug 16, 2018 · Completed: Dec 31, 2024
4 conditions
1 sponsor
1 location
NCT03709784
Spinraza in Adult Spinal Muscular Atrophy
N/A
Active, not recruiting
148 participants
Started: Aug 16, 2018 · Completed: Jan 1, 2025
3 conditions
1 sponsor
11 locations
NCT03793478
Safety and Efficacy of Quizartinib in Children and Young Adults With Acute Myeloid Leukemia (AML), a Cancer of the Blood
PHASE1/PHASE2
Active, not recruiting
65 participants
Started: Aug 15, 2018 · Completed: May 1, 2027
1 condition
3 sponsors
27 locations
NCT03535142
Prognostic Significance of Fatty Liver Disease in Bariatric Patients
NA
Recruiting
1,200 participants
Started: Aug 15, 2018 · Completed: Apr 1, 2038
4 conditions
4 sponsors
1 location
NCT03825120
The Longitudinal Evaluation of Ovarian Aging and Cardiovascular Risk
N/A
Enrolling by invitation
865 participants
Started: Aug 15, 2018 · Completed: Dec 2, 2025
2 conditions
2 sponsors
1 location
NCT03631979
Intestinal Lavage to Promote Enteral Feeding and Prevent Necrotizing Enterocolitis in Extremely Preterm Infants
NA
Recruiting
200 participants
Started: Aug 15, 2018 · Completed: Nov 30, 2031
2 conditions
1 sponsor
1 location
NCT03391479
A Study of Avelumab in Penile Cancer Who Are Unfit for or Have Progressed After Platinum-Based Chemotherapy
PHASE2
Recruiting
24 participants
Started: Aug 15, 2018 · Completed: Dec 31, 2024
3 conditions
1 sponsor
1 location
NCT03610763
Harnessing Neuroplasticity to Enhance Functional Recovery During Chronic Recovery From Upper Extremity Nerve Repair
NA
Recruiting
180 participants
Started: Aug 15, 2018 · Completed: Jun 1, 2025
3 conditions
3 sponsors
3 locations
NCT03696043
External Ventricular Drain Placement Stealth Study
NA
Recruiting
100 participants
Started: Aug 15, 2018 · Completed: Dec 31, 2026
2 conditions
1 sponsor
1 location
NCT03389230
Memory-Enriched T Cells in Treating Patients With Recurrent or Refractory Grade III-IV Glioma
PHASE1
Active, not recruiting
29 participants
Started: Aug 14, 2018 · Completed: Jan 12, 2026
5 conditions
2 sponsors
1 location
NCT03502733
Testing the Combination of Copanlisib, Nivolumab and Ipilimumab in Patients With Advanced Cancer and Lymphoma
PHASE1
Active, not recruiting
64 participants
Started: Aug 14, 2018 · Completed: Jul 1, 2026
4 conditions
1 sponsor
3 locations
NCT04326946
International Alfapump Cohort Study
N/A
Active, not recruiting
400 participants
Started: Aug 14, 2018 · Completed: Dec 31, 2030
2 conditions
1 sponsor
2 locations
NCT03603951
A Phase 1 Study of SHR2554 in Subjects With Relapsed or Refractory Mature Lymphoid Neoplasms
PHASE1
Active, not recruiting
272 participants
Started: Aug 14, 2018 · Completed: Aug 14, 2026
1 condition
2 sponsors
1 location
NCT04277858
Neoadjuvant Chemotherapy and Transoral Robotic Surgery for Oropharyngeal Cancer.
PHASE2
Recruiting
60 participants
Started: Aug 14, 2018 · Completed: Aug 30, 2026
4 conditions
2 sponsors
1 location
NCT03941756
Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or Melanoma
NA
Recruiting
252 participants
Started: Aug 14, 2018 · Completed: Dec 31, 2025
4 conditions
2 sponsors
1 location
NCT03432520
Long-Term Safety and Efficacy of Spark-Sponsored Gene Therapies in Males With Hemophilia A
N/A
Active, not recruiting
29 participants
Started: Aug 14, 2018 · Completed: Dec 31, 2032
1 condition
1 sponsor
12 locations
NCT03629418
Targeted Blood-pressure Management and Acute Kidney Injury After Coronary Artery Bypass Surgery
NA
Recruiting
612 participants
Started: Aug 14, 2018 · Completed: Jul 31, 2026
5 conditions
1 sponsor
1 location
NCT03547973
Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread
PHASE2
Recruiting
827 participants
Started: Aug 13, 2018 · Completed: Jun 30, 2030
1 condition
2 sponsors
135 locations
NCT03673787
A Trial of Ipatasertib in Combination With Atezolizumab
PHASE1/PHASE2
Active, not recruiting
87 participants
Started: Aug 13, 2018 · Completed: Mar 31, 2026
3 conditions
2 sponsors
1 location
NCT03635892
A Study of Nivolumab In Combination With Cabozantinib in Patients With Non-Clear Cell Renal Cell Carcinoma
PHASE2
Active, not recruiting
60 participants
Started: Aug 13, 2018 · Completed: Aug 31, 2026
7 conditions
1 sponsor
7 locations
NCT03658512
Tübinger Diabetes Mellitus Database (TUEDID)
N/A
Recruiting
1,000 participants
Started: Aug 13, 2018 · Completed: Feb 1, 2028
1 condition
1 sponsor
1 location
NCT03619850
A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD)
PHASE3
Recruiting
129 participants
Started: Aug 13, 2018 · Completed: Aug 31, 2024
1 condition
1 sponsor
21 locations
NCT04703738
Evaluation of Geistlich Fibro-Gide® in Comparison to CTG for the Treatment Around Implants
NA
Active, not recruiting
60 participants
Started: Aug 13, 2018 · Completed: Dec 31, 2025
1 condition
2 sponsors
5 locations
NCT03586453
Osimertinib In EGFR Mutant Lung Cancer
PHASE2
Recruiting
30 participants
Started: Aug 13, 2018 · Completed: Mar 1, 2027
1 condition
2 sponsors
2 locations
NCT03569293
Evaluation of Upadacitinib in Adolescent and Adult Patients With Moderate to Severe Atopic Dermatitis (Eczema)
PHASE3
Active, not recruiting
912 participants
Started: Aug 13, 2018 · Completed: Oct 9, 2025
1 condition
1 sponsor
180 locations
NCT04498806
Activity Monitors as a Measure of Physical Function in Degenerative Cervical Myelopathy
NA
Enrolling by invitation
200 participants
Started: Aug 13, 2018 · Completed: Aug 31, 2026
1 condition
1 sponsor
1 location
NCT03630536
TFE Renal Cell Carcinoma: A Prospective Registry and Translational Research Initiative
N/A
Recruiting
500 participants
Started: Aug 12, 2018 · Completed: May 8, 2028
1 condition
1 sponsor
1 location
NCT03552003
Study for Elderly (≥ 65 Years) Patients With Classical Hodgkin Lymphoma Undergoing CGA at Diagnosis
N/A
Recruiting
400 participants
Started: Aug 10, 2018 · Completed: Jan 31, 2026
1 condition
1 sponsor
44 locations
NCT03613545
Fecal Microbiota Transplantation for Irritable Bowel Syndrome
PHASE2/PHASE3
Recruiting
120 participants
Started: Aug 10, 2018 · Completed: Dec 31, 2030
2 conditions
1 sponsor
1 location
NCT03631017
Imaging With a PET Agent for Detection of Cancers of the Head and Neck
PHASE1/PHASE2
Active, not recruiting
12 participants
Started: Aug 10, 2018 · Completed: Aug 31, 2026
1 condition
1 sponsor
1 location
NCT03563716
A Study of Tiragolumab in Combination With Atezolizumab in Chemotherapy-Naïve Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
PHASE2
Active, not recruiting
135 participants
Started: Aug 10, 2018 · Completed: Aug 31, 2025
1 condition
1 sponsor
37 locations
NCT03552718
QUILT-2.025 NANT Neoepitope Yeast Vaccine (YE-NEO-001): Adjuvant Immunotherapy Using a Personalized Neoepitope Yeast-Based Vaccine To Induce T-Cell Responses In Subjects W/ Previously Treated Cancers.
PHASE1
Active, not recruiting
16 participants
Started: Aug 10, 2018 · Completed: Dec 30, 2025
7 conditions
1 sponsor
1 location
NCT03474822
Plasmodium Immunotherapy for Breast and Liver Cancers
PHASE1/PHASE2
Recruiting
60 participants
Started: Aug 10, 2018 · Completed: Jun 30, 2026
2 conditions
1 sponsor
1 location
NCT04139343
Motor Unit Number Estimation (MUNE) in Adults With Spinal Muscular Atrophy (SMA)
N/A
Active, not recruiting
140 participants
Started: Aug 10, 2018 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT03563248
Losartan and Nivolumab in Combination With FOLFIRINOX and SBRT in Localized Pancreatic Cancer
PHASE2
Active, not recruiting
168 participants
Started: Aug 10, 2018 · Completed: Apr 30, 2027
1 condition
4 sponsors
10 locations
NCT05311397
A Study of A166 in Patients With Advanced Solid Malignant Tumors
PHASE1
Recruiting
120 participants
Started: Aug 9, 2018 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT03480061
Dexmedetomidine to Reduce the Incidence of POCD After Open Cardiac Surgery
PHASE4
Active, not recruiting
90 participants
Started: Aug 9, 2018 · Completed: Dec 31, 2026
5 conditions
1 sponsor
1 location
NCT03278925
Defined Green Tea Catechin Extract in Preventing Liver Cancer in Participants With Cirrhosis
PHASE1
Active, not recruiting
14 participants
Started: Aug 9, 2018 · Completed: Dec 31, 2024
1 condition
1 sponsor
2 locations
NCT03529110
DS-8201a Versus T-DM1 for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive, Unresectable and/or Metastatic Breast Cancer Previously Treated With Trastuzumab and Taxane [DESTINY-Breast03]
PHASE3
Active, not recruiting
524 participants
Started: Aug 9, 2018 · Completed: Jul 30, 2026
1 condition
3 sponsors
164 locations
NCT02991469
A Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Systemic Juvenile Idiopathic Arthritis (SKYPS)
PHASE2
Recruiting
51 participants
Started: Aug 9, 2018 · Completed: Feb 19, 2029
1 condition
2 sponsors
29 locations
NCT03575910
HEARTBiT: Multi-Marker Blood Test for Acute Cardiac Transplant Rejection
N/A
Active, not recruiting
196 participants
Started: Aug 9, 2018 · Completed: Dec 30, 2025
6 conditions
7 sponsors
4 locations
NCT03568318
A Study to Evaluate Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis
PHASE3
Enrolling by invitation
1,500 participants
Started: Aug 9, 2018 · Completed: Oct 23, 2030
1 condition
1 sponsor
193 locations
NCT06552676
riSk Factors fOR neCk phlEgmon afteR pErcutaneous tRacheostomy in ICU
N/A
Recruiting
300 participants
Started: Aug 9, 2018 · Completed: Jan 31, 2025
2 conditions
1 sponsor
1 location
NCT04994067
Intra-Operative Radiation Registry
N/A
Recruiting
500 participants
Started: Aug 9, 2018 · Completed: Aug 31, 2032
1 condition
1 sponsor
1 location
NCT03526432
Phase II Study of Atezolizumab + Bevacizumab in Endometrial Cancer
PHASE2
Active, not recruiting
110 participants
Started: Aug 8, 2018 · Completed: Sep 30, 2025
1 condition
2 sponsors
3 locations
Previous
1
More pages
2172
2173
2174
2175
2176
2177
2178
More pages
2369
Next